SILAC-based proteomic profiling of the human MDA-MB-231 metastatic breast cancer cell line in response to the two antitumoral lactoferrin isoforms: The secreted lactoferrin and the intracellular delta-lactoferrin

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hoedt, Esthelle ^a   Chaoui, Karima ^b,c   Huvent, Isabelle ^a   Mariller, Christophe ^a   Monsarrat, Bernard ^b,c   Burlet Schiltz, Odile ^b,c   Pierce, Annick ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LACTOFERRIN; LACTOFERRIN; MESSENGER RNA; UBIQUITIN; UNCLASSIFIED DRUG; ISOPROTEIN; PROTEIN BINDING; PROTEOME; RECOMBINANT PROTEIN; SELENOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR II; TRANSCRIPTION FACTOR TFIIF; UBE2E1 PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENERAL TRANSCRIPTION FACTOR IIF 2 GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEOMICS; RNA TRANSLATION; SELENOPROTEIN H GENE; UBIQUITIN CONJUGATING ENZYME E1 GENE; ALTERNATIVE RNA SPLICING; BREAST TUMOR; DNA RESPONSIVE ELEMENT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; ISOTOPE LABELING; METABOLISM; METASTASIS; PATHOLOGY; PROCEDURES; PROMOTER REGION; REPRODUCIBILITY; TUMOR CELL LINE;

ALTERNATIVE SPLICING; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOTOPE LABELING; LACTOFERRIN; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEOME; PROTEOMICS; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RESPONSE ELEMENTS; SELENOPROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84905852303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104563     Document Type: Article

References (78)

1. Masson PL, Heremans JF, Schonne E (1969) Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 130: 643-658.
2. Siebert PD, Huang BC (1997) Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA 94: 2198-2203. (Pubitemid 27136851)
3. Liu D, Wang X, Zhang Z, Teng CT (2003) An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem Biophys Res Commun 301: 472-479. (Pubitemid 36279264)
4. Benaïssa M, Peyrat J, Hornez L, Mariller C, Mazurier J, et al. (2005) Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer. Int J Cancer 114: 299-306. (Pubitemid 40194300)
5. Hoedt E, Hardivillé S, Mariller C, Elass E, Perraudin J, et al. (2010) Discrimination and evaluation of lactoferrin and delta-lactoferrin gene expression levels in cancer cells and under inflammatory stimuli using TaqMan real-time PCR. Biometals 23: 441-452.
6. Sousa JF, Ham AL, Whitwell C, Nam KT, Lee H, et al. (2012) Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol 181: 1560-1572.
7. Panella TJ, Liu YH, Huang AT, Teng CT (1991) Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer Cancer Res 51: 3037-3043.
8. Teng CT, Gladwell W, Raphiou I, Liu E (2004) Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 17: 317-323. (Pubitemid 38987156)
9. Legrand D (2012) Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 90: 252-268.
10. Vogel HJ (2012) Lactoferrin, a bird's eye view. Biochem Cell Biol 90: 233-244.
11. Mariller C, Hardivillé S, Hoedt E, Huvent I, Pina-Canseco S, et al. (2012) Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem Cell Biol 90: 307-319.
12. Penco S, Scarfi S, Giovine M, Damonte G, Millo E, et al. (2001) Identification of an import signal for, and the nuclear localization of, human lactoferrin. Biotechnol Appl Biochem 34: 151-159. (Pubitemid 33152512)
13. Mariller C, Benaïssa M, Hardivillé S, Breton M, Pradelle G, et al. (2007) Human delta-lactoferrin is a transcription factor that enhances Skp1 (S-phase kinase-associated protein) gene expression. FEBS J 274: 2038-2053. (Pubitemid 46588002)
14. Goldberg GS, Kunimoto T, Alexander DB, Suenaga K, Ishidate F, et al. (2005) Full length and delta lactoferrin display differential cell localization dynamics, but do not act as tumor markers or significantly affect the expression of other genes. Med Chem 1: 57-64.
15. Hardivillé S, Hoedt E, Mariller C, Benaïssa M, Pierce A (2010) O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin. J Biol Chem 285: 19205-19218.
16. Suzuki YA, Lopez V, Lönnerdal B (2005) Mammalian lactoferrin receptors: structure and function. Cell Mol Life Sci 62: 2560-2575. (Pubitemid 41721230)
17. Legrand D, Vigie K, Said EA, Elass E, Masson M, et al. (2004) Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271: 303-317. (Pubitemid 38130458)
18. Håversen L (2002) Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kB. Cell Immunol 220: 83-95.
19. Akiyama Y, Oshima K, Shin K, Wakabayashi H, Abe F, et al. (2013) Intracellular retention and subsequent release of bovine milk lactoferrin taken up by human enterocyte-like cell lines, Caco-2, C2BBe1 and HT-29. Biosci Biotechnol Biochem 77: 1023-1029.
20. Baker HM, Baker EN (2012) A structural perspective on lactoferrin function. Biochem Cell Biol 90: 320-328.
21. Spik G, Coddeville B, Montreuil J (1988) Comparative study of the primary structures of sero-, lacto- and ovotransferrin glycans from different species. Biochimie 70: 1459-1469.
22. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, et al. (2008) Lactoferrin structure and functions. Adv Exp Med Biol 606: 163-194.
23. Bezault J, Bhimani R, Wiprovnick J, Furmanski P (1994) Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54: 2310-2312. (Pubitemid 24138715)
24. Tsuda H, Kozu T, Iinuma G, Ohashi Y, Saito Y, et al. (2010) Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 23: 399-409.
25. Yin CM, Wong JH, Xia J, Ng TB (2013) Studies on anticancer activities of lactoferrin and lactoferricin. Curr Protein Pept Sci 14: 492-503.
26. Komiya M, Fujii G, Takahashi M, Iigo M, Mutoh M. (2013) Prevention and intervention trials for colorectal cancer. Jpn J Clin Oncol 43: 685-694.
27. Habib HM, Ibrahim WH, Schneider-Stock R, Hassan HM (2013) Camel milk lactoferrin reduces the proliferation of colorectal cancer cells and exerts antioxidant and DNA damage inhibitory activities. Food Chem 141: 148-152.
28. Damiens E, Yazidi I, Mazurier J, Duthille I, Spik G, et al. (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74: 486-498. (Pubitemid 29344898)
29. Xiao Y (2004) Lactoferrin down-regulates g1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res 10: 8683-8686.
30. Son H, Lee S, Choi S (2006) Human lactoferrin controls the level of retinoblastoma protein and its activity. Biochem Cell Biol 84: 345-350. (Pubitemid 44341309)
31. Deng M, Zhang W, Tang H, Ye Q, Liao Q, et al. (2013) Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene 32: 4273-4283.
32. Oh SM, Pyo CW, Kim Y, Choi SY (2004) Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 23: 8282-8291. (Pubitemid 39531839)
33. Zemann N, Klein P, Wetzel E, Huettinger F, Huettinger M (2010) Lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in HeLa cells. Biochimie, 92: 880-884.
34. Kanwar RK, Kanwar JR (2013) Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer. Protein Pept Lett 20: 450-458.
35. Fujita K, Matsuda E, Sekine K, Iigo M, Tsuda H (2004) Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25: 1961-1966. (Pubitemid 39405916)
36. Lee S, Park S, Pyo C, Yoo N, Kim J, et al. (2009) Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line. Biochimie 91: 102-108.
37. Lee S, Hwang H, Pyo C, Hahm DH, Choi S (2010) E2F1-directed activation of Bcl-2 is correlated with lactoferrin-induced apoptosis in Jurkat leukemia T lymphocytes. Biometals 23: 507-514.
38. Lin T, Chiou S, Chen M, Kuo C (2005) Human lactoferrin exerts bi-directional actions on PC12 cell survival via ERK1/2 pathway. Biochem Biophys Res Commun 337: 330-336. (Pubitemid 41393798)
39. Li WY, Li QW, Han ZS, Jiang ZL, Yang H, et al. (2011) Growth suppression effects of recombinant adenovirus expressing human lactoferrin on cervical cancer in vitro and in vivo. Cancer Biother Radiopharm 26: 477-483.
40. Wang J, Li Q, Ou Y, Han Z, Li K, et al. (2011) Inhibition of tumor growth by recombinant adenovirus containing human lactoferrin through inducing tumor cell apoptosis in mice bearing EMT6 breast cancer. Arch Pharm Res 34: 987-995.
41. Breton M, Mariller C, Benaïssa M, Caillaux K, Browaeys E, et al. (2004) Expression of delta-lactoferrin induces cell cycle arrest. Biometals 17: 325-329. (Pubitemid 38987157)
42. Hardivillé S, Escobar-Ramirez A, Pina-Canceco S, Elass E, Pierce A (2014) Delta-lactoferrin induces cell death via the mitochondrial death signaling pathway by upregulating Bax expression. Biometals DOI: 10.1007/s10534-014-9744-5
43. He J, Furmanski P (1995) Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373: 721-724.
44. Son K, Park J, Chung C, Chung DK, Yu D, et al. (2002) Human lactoferrin activates transcription of IL-1beta gene in mammalian cells. Biochem Biophys Res Commun 290: 236-241. (Pubitemid 34694489)
45. Ha NH, Nair VS, Reddy SDN, Mudvari P, Ohshiro K, et al. (2011) Lactoferrin-endothelin-1 axis contributes to the development and invasiveness of triple negative breast cancer phenotypes. Cancer Res 71: 7259-7269.
46. Kim CW, Lee TH, Park KH, Choi S-Y, Kim J (2012) Human lactoferrin suppresses TNF-a-induced intercellular adhesion molecule-1 expression via competition with NF-kB in endothelial cells. FEBS Lett 586: 229-234.
47. Mariller C, Hardivillé S, Hoedt E, Benaïssa M, Mazurier J, et al. (2009) Proteomic approach to the identification of novel delta-lactoferrin target genes: Characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie 91: 109-122.
48. Kim B, Kang S, Kim SJ (2013) Genome-wide pathway analysis reveals different signaling pathways between secreted lactoferrin and intracellular delta-lactoferrin. PLoS One 8: e55338. doi: 10.1371/journal.pone.0055338.
49. Ong S, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
50. Ong S, Foster LJ, Mann M (2003) Mass spectrometric-based approaches in quantitative proteomics. Methods 29: 124-130. (Pubitemid 36269199)
51. Blagoev B, Kratchmarova I, Ong S, Nielsen M, Foster LJ, et al. (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21: 315-318. (Pubitemid 36314817)
52. Elass E, Masson M, Mazurier J, Legrand D (2002) Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70: 1860-1866. (Pubitemid 34245400)
53. Misawa Y, Li Y, Rekosh D, Hammarskjold ML (2006) Western blot analysis of sub-cellular fractionated samples using the Odyssey Infrared Imaging System. Protocol Exchange doi:10.1038/nprot.2006.219
54. Bouyssié D, Gonzalez de Peredo A, Mouton E, Albigot R, Roussel L, et al. (2007) Mascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: application to the proteomics study of membrane proteins from primary human endothelial cells. Mol Cell Proteomics 6: 1621-1637. (Pubitemid 47506172)
55. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
56. Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
57. Mi H, Muruganujan A, Casagrande JT, Thomas PD (2013) PANTHER Classification System: large-scale gene function analysis with the PANTHER classification system. Nature Protoc 8: 1551-1566.
58. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
59. Novoselov SV, Kryukov GV, Xu X, Carlson BA, Hatfield DL, et al. (2007) Selenoprotein H is a nucleolar thioredoxin-like protein with a unique expression pattern. J Biol Chem 282: 11960-11968. (Pubitemid 47100687)
60. Mendelev N, Witherspoon S, Li PA (2009) Overexpression of human selenoprotein H in neuronal cells ameliorates ultraviolet irradiation-induced damage by modulating cell signaling pathways. Exp Neurol 220: 328-334.
61. Krishnan N, Dickman MB, Becker DF (2008) Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. Free Radic Biol Med 44: 671-681. (Pubitemid 351172717)
62. Kim SY, Lee M, Cho KC, Choi Y, Choi J, et al. (2003) Alterations in mRNA expression of ribosomal protein S9 in hydrogen peroxide-treated neurotumor cells and in rat hippocampus after transient ischemia. Neurochem Res 28: 925-931. (Pubitemid 36438411)
63. Wang J, Chen L, Li Y, Guan X-Y (2011) Overexpression of cathepsin z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. PLoS One 6: e24967. doi:10.1371/journal.pone.0024967
64. Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, et al. (2013) High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer. BMC Cancer 13: 13-47.
65. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature Med 5: 793-802. (Pubitemid 29318614)
66. Oh SM, Hahm DH, Kim IH, Choi SY (2001) Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J Biol Chem 276: 42575-42579.
67. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364. (Pubitemid 351381290)
68. Fensterl V, Sen GC (2011) The ISG56/IFIT1 Gene Family. J Interferon Cytokine Res 31: 71-78.
69. Danish HH, Goyal S, Taunk NK, Wu H, Moran MS, et al. (2013) Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy. Breast J 19: 231-239.
70. Lai KC, Chang KW, Liu CJ, Kao SY, Lee TC (2008) IFIT2 protein inhibits migration activity and increases survival in oral squamous cell carcinoma. Mol Cancer Res 6: 1-9.
71. Lai KC, Liu CJ, Chang KW, Lee TC (2013) Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells. Oncogene 32: 3686-3697.
72. Reich NC (2013) A death-promoting role for ISG54/IFIT2. J Interferon Cytokine Res 33: 199-205.
73. Terenzi F, Hui DJ, Merrick WC, Sen GC (2006) Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem 281: 34064-34071. (Pubitemid 46036616)
74. Xiao S, Li D, Zhu HQ, Song MG, Pan XR, et al. (2006) RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA 103: 16448-16453. (Pubitemid 44715216)
75. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102: 10200-10205. (Pubitemid 41023349)
76. Srivastava M, Pollard HB (1999) Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 13: 1911-1922. (Pubitemid 29517621)
77. van Wijk SJ, Timmers HT (2010) The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J 24: 981-993.
78. Tan S, Aso T, Conaway RC, Conaway JW (1994) Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II. J Biol Chem 269: 25684-25691. (Pubitemid 24336264)